FCGSX | VIGAX | FCGSX / VIGAX | |
Total Expense Ratio | 0.00 | 0.05 | - |
Annual Report Gross Expense Ratio | 0.00 | 0.05 | - |
Fund Existence | 12 years | 25 years | - |
Gain YTD | 5.799 | 7.727 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.8B | 294B | 6% |
Annual Yield % from dividends | 0.44 | 0.45 | 98% |
Returns for 1 year | 1.60 | 15.43 | 10% |
Returns for 3 years | 86.21 | 96.41 | 89% |
Returns for 5 years | 14.89 | 115.36 | 13% |
Returns for 10 years | 105.50 | 312.86 | 34% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MSTQ | 36.40 | 0.58 | +1.63% |
LHA Market State™ Tactical Q ETF | |||
ROBT | 49.17 | 0.70 | +1.44% |
FT Nasdaq Artfcl Intllgnc and Rbtc ETF | |||
IHI | 62.30 | 0.14 | +0.23% |
iShares US Medical Devices ETF | |||
INDS | 37.58 | 0.08 | +0.22% |
Pacer Benchmark Industrial RE SCTR ETF | |||
DXIV | 58.24 | 0.02 | +0.03% |
Dimensional International Vector Eq ETF |